Search research articles
Contact Us
Filters
Showing results (21-30 of 379) with videos related to
Page
of 38
Sort By:
The Breast Journal
|
June 12, 2012
Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitors
Rowan T Chlebowski, Nananda Col
Clinical Breast Cancer
|
September 3, 2005
Abnormal mammographic findings with short-interval follow-up recommendation
Rowan T Chlebowski, Iraj Khalkhali
Clinical Breast Cancer
|
February 8, 2014
Adjuvant endocrine therapy of perimenopausal and recently postmenopausal women with hormone receptor-positive breast cancer
Kathy Pan, Rowan T Chlebowski
Anti-Cancer Agents in Medicinal Chemistry
|
August 26, 2011
Bisphosphonates and breast cancer prevention
Rowan T Chlebowski, Nananda Col
The Surgical Clinics of North America
|
October 1, 1986
Metabolic abnormalities in cancer patients: carbohydrate metabolism
R T Chlebowski, D Heber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2016
Weight Loss Randomized Intervention Trials in Female Cancer Survivors
Rowan T Chlebowski, Marina M Reeves
Journal of the National Cancer Institute
|
March 20, 2012
Changing concepts: Menopausal hormone therapy and breast cancer
Rowan T Chlebowski, Garnet L Anderson
Menopause (New York, N.Y.)
|
August 14, 2008
Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk
Nananda F Col, Rowan T Chlebowski
Therapeutic Advances in Drug Safety
|
April 30, 2015
Menopausal hormone therapy and breast cancer mortality: clinical implications
Rowan T Chlebowski, Garnet L Anderson
JPEN. Journal of Parenteral and Enteral Nutrition
|
November 1, 1992
Metabolic response to chemotherapy in colon cancer patients
J A Tayek, R T Chlebowski
Page
of 38
Search research articles
Search
Showing results (21-30 of 379) with videos related to
Sort By:
Page
of 38
The Breast Journal
|
June 12, 2012
Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitors
Rowan T Chlebowski, Nananda Col
Clinical Breast Cancer
|
September 3, 2005
Abnormal mammographic findings with short-interval follow-up recommendation
Rowan T Chlebowski, Iraj Khalkhali
Clinical Breast Cancer
|
February 8, 2014
Adjuvant endocrine therapy of perimenopausal and recently postmenopausal women with hormone receptor-positive breast cancer
Kathy Pan, Rowan T Chlebowski
Anti-Cancer Agents in Medicinal Chemistry
|
August 26, 2011
Bisphosphonates and breast cancer prevention
Rowan T Chlebowski, Nananda Col
The Surgical Clinics of North America
|
October 1, 1986
Metabolic abnormalities in cancer patients: carbohydrate metabolism
R T Chlebowski, D Heber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2016
Weight Loss Randomized Intervention Trials in Female Cancer Survivors
Rowan T Chlebowski, Marina M Reeves
Journal of the National Cancer Institute
|
March 20, 2012
Changing concepts: Menopausal hormone therapy and breast cancer
Rowan T Chlebowski, Garnet L Anderson
Menopause (New York, N.Y.)
|
August 14, 2008
Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk
Nananda F Col, Rowan T Chlebowski
Therapeutic Advances in Drug Safety
|
April 30, 2015
Menopausal hormone therapy and breast cancer mortality: clinical implications
Rowan T Chlebowski, Garnet L Anderson
JPEN. Journal of Parenteral and Enteral Nutrition
|
November 1, 1992
Metabolic response to chemotherapy in colon cancer patients
J A Tayek, R T Chlebowski
Page
of 38